On May 6, 2022 Nykode Therapeutics AS (Euronext Growth (Oslo): NYKD), a clinicalstage biopharmaceutical company dedicated to the discovery and development of vaccines and novel immunotherapies, reported to a Capital Markets Day for analysts and investors in Oslo, Norway, on May 12, from 2.00-4.00 p.m. CET / 8.00-10.00 a.m. ET (Press release, Nykode Therapeutics, MAY 6, 2022, View Source [SID1234613790]). The event will be hosted both with the possibility for physical attendance and as a live webcast from Nykode’s facilities in Oslo, Norway, and will take place in English.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The Capital Markets Day will feature Nykode’s Executive Management Team who will provide updates on Nykode’s business, pipeline, and innovations. All sessions are webcasted live, and a replay will be made available on the investor section of nykode.com. The presentation material from the Capital Markets Day will also be available on the day from 8.00 a.m. CET on the investor section of nykode.com.
Topics of the Capital Markets Day will include:
• Nykode’s business status and journey
• Pipeline update – Overview of Nykode’s product candidate pipeline and clinical experience
• Research update – Deep dive into Nykode’s research and the ongoing technology projects
• Capital market strategy update, including potential uplisting to the main market of Oslo Stock
Exchange (Oslo Børs)
Physical attendance requires registration. To register for the physical event, please send an email to
[email protected] before May 11 at 3.00 p.m. CET.